To be given approval to sell a2 platinum formula in the US market until November 2022 would be a short term sugar hit, maybe we could jag $30 -$40 million NZD in sales.
The real upside is if A2 mngt and the FDA ( with help from NZ govt) can negotiate a longer term supply access deal and get the 17.5% Tariff waived so our products would be competitive with local infant formulas.
This would give A2 a real diversification from the Chinese market and provide serious scope to develop their US business including adding adult milk powders.
FDA Approval
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.29 |
Change
0.165(2.32%) |
Mkt cap ! $5.255B | |||
| Open | High | Low | Value | Volume |
| $7.15 | $7.32 | $7.11 | $22.41M | 3.098M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 28170 | $7.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.29 | 10667 | 26 |
View Market Depth
| Last trade - 15.11pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.29 |
Change
0.165 ( 2.20 %) |
||||
| Open | High | Low | Volume | ||
| $7.16 | $7.32 | $7.11 | 887908 | ||
| Last updated 15.34pm 27/05/2024 ? | |||||
| A2M (ASX) Chart |